D. Cazals

Hepatitis after intravenous buprenorphine misuse in heroin addicts.

P. Marcellin, D. Pessayre, D. Valla, 2001, Journal of hepatology.

Serum p53 antibodies as early markers of lung cancer

T. Soussi, R. Lubin, J. Trédaniel, 1995, Nature Medicine.

Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas

T. Molina, C. Gisselbrecht, N. Mounier, 1998, Leukemia.

Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: comparison of bone marrow and peripheral blood progenitor cells.

H. Dombret, C. Gisselbrecht, D. Cazals, 1996, Leukemia & lymphoma.

Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).

C. Gisselbrecht, É. Lepage, M. André, 1997, Hematology and cell therapy.

BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases.

P. Gaulard, R. Berger, C. Larsen, 1993, Leukemia.

Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, B. Coiffier, J. Diebold, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiple biliary hamartomas: magnetic resonance features with histopathologic correlation

V. Vilgrain, D. Valla, D. Cazals, 2008, European Radiology.

Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3

C. Degott, Y. DeClerck, J. Vigneron, 2003, Cancer Gene Therapy.

Antibodies to HTLV-I in Sjögren's syndrome

X. Mariette, L. Bélec, D. Cazals, 1995, The Lancet.